GT Biopharma is set to begin a Phase I trial in mid-2026 of its B7-H3-targeting natural killer cell engager, after the US Food and Drug Administration cleared its investigational new drug application ...
Bowing at Sundance, ESPN’s latest ‘30 for 30’ installment focuses on Griner's detention after being arrested and charged with ...
Shares of Adicet Bio, Inc. (NASDAQ: ACET) are trading lower after the clinical stage biotechnology company announced a one-for-16 reverse stock split. The move, expected to take effect on Dec. 30, ...
William Robert Greiner , 87, affectionately known as “Bill the Barber of Down Town Swamp” has gone to his Heavenly home early Friday morning to be with his Lord and Savior, Jesus Christ. Bill, a ...
– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engager and Phagocytosis Platform to discover first-in-class ...
James G. Greiner, loving husband, father, and grandfather, went home to be with the Lord on December 10, 2025. He was 92 years old. Born at the home of his aunt and uncle in Ephrata, Jim was the son ...
We now know what Bianca Censori’s BIO POP (THE ORIGIN) is, and furniture does play a key part after all. Thursday (Dec. 11), Censori launched the previously teased project in Seoul, revealing—as had ...
AI-generated summary reviewed by our newsroom. Read our AI Policy. Sam Greiner relieved as West Charlotte coach; CMS opened paid suspension probe Greiner led program to multiple winning seasons, two ...
Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.
Curi Bio’s ribbon cutting in April 2025 for its new headquarters on Seattle’s waterfront. Elliot Fisher, co-founder and chief business officer, cuts the ribbon with a sword while CEO Nicholas Geisse ...
A paralyzed man says he can now play first-person shooters like “Battlefield 6” using a Neuralink brain implant. “I can now aim with my thoughts,” wrote Rob Greiner, who is paralyzed from the ...
Who would have predicted that one of the hottest trends for beleaguered biotechs in 2025 would be to rebrand as a crypto company? Leap Therapeutics has became the latest drug developer to make the ...